Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006254 · ClinicalTrials.gov registry record · Phase 1
VNP20009 in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Vion Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006254 is a Phase 1 study that has completed, run by Vion Pharmaceuticals.
The verdict
NCT00006254, a Phase 1 study, has completed, sponsored by Vion Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced solid tumors.
Interventions
- BIOLOGICAL salmonella VNP20009
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-05 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006254
The ClinicalTrials.gov registry entry for NCT00006254 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Vion Pharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which salmonella VNP20009 is the first listed.
NCT00006254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006254 about?
NCT00006254 is a clinical study titled "VNP20009 in Treating Patients With Advanced Solid Tumors". RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced solid tumors.
What is the current status of trial NCT00006254?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-05. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00006254?
The interventions under investigation include: salmonella VNP20009 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00006254?
This trial is sponsored by Vion Pharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.